Discussion Paper Example

FDA’s Generative AI Discussion Paper Signals a Break from the Past in Terminology, But Will a New Regulatory Approach Materialize?

The U.S. Food and Drug Administration’s (FDA) recently released discussion paper on generative artificial intelligence (GenAI)-enabled medical ...

Some results have been hidden because they may be inaccessible to you